Home Your basket
• An important procedure in...
   Price 8.50 €
• Functional septal surgery...
   Price 10.50 €
• Metastatic melanoma to th...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Early evaluation of voice...
   Price 12.00 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Planned reconstruction af...
   Price 8.50 €
• What is the effect of diz...
   Price 10.50 €
• Fistula of the fourth bra...
   Price 5.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Cottle's technique septop...
   Price 5.50 €
• A simple assessment of qu...
   Price 10.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Persistent stapedial arte...
   Price 5.50 €
• Importance of a molding n...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• Oculo-orbital complicatio...
   Price 14.00 €
• Supra and infra hyoid mid...
   Price 10.50 €
• A rare tumor of the parap...
   Price 5.50 €
• Influence of phonetic con...
   Price 10.50 €
• Quality of life after oro...
   Price 10.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• High click stimulus repet...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• A new case of rhinosclero...
   Price 5.50 €
• Eagle syndrom: A case rep...
   Price 8.50 €
• Exploration of the otolit...
   Price 10.50 €
• Adenomatoid hamartoma of ...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Isolated tracheo-œsophage...
   Price 5.50 €
• Contribution to anatomica...
   Price 10.50 €
• Implementation of the Eur...
   Price 10.50 €
• Botulinum toxin, descript...
   Price 12.50 €

Total Order 339.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE